Sirio Pharma (300791) - Total Liabilities

Latest as of June 2025: CN¥3.07 Billion CNY ≈ $449.47 Million USD

Based on the latest financial reports, Sirio Pharma (300791) has total liabilities worth CN¥3.07 Billion CNY (≈ $449.47 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Sirio Pharma to track the company's year-over-year net asset growth rate.

Sirio Pharma - Total Liabilities Trend (2016–2024)

This chart illustrates how Sirio Pharma's total liabilities have evolved over time, based on quarterly financial data. See Sirio Pharma free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Sirio Pharma Competitors by Total Liabilities

The table below lists competitors of Sirio Pharma ranked by their total liabilities.

Company	Country	Total Liabilities
Guoguang Electric Co Ltd Chengdu SHG:688776	China	CN¥589.04 Million
Hangzhou Youngsun Intelligent SHG:603901	China	CN¥5.35 Billion
Hudson Pacific Properties Inc NYSE:HPP	USA	$4.31 Billion
XiAn Tian He Defense Technology Co Ltd SHE:300397	China	CN¥1.29 Billion
McCormick & Company Incorporated NYSE:MKC-V	USA	$8.79 Billion
Henan Senyuan Electric Co Ltd SHE:002358	China	CN¥3.73 Billion
Clairvest Group Inc. TO:CVG	Canada	CA$151.20 Million
Magazine Luiza S.A SA:MGLU3	Brazil	R$25.44 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Sirio Pharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sirio Pharma stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.20	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.54	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sirio Pharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sirio Pharma (2016–2024)

The table below shows the annual total liabilities of Sirio Pharma from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.84 Billion ≈ $416.29 Million	+8.19%
2023-12-31	CN¥2.63 Billion ≈ $384.79 Million	+77.16%
2022-12-31	CN¥1.48 Billion ≈ $217.20 Million	+16.38%
2021-12-31	CN¥1.28 Billion ≈ $186.62 Million	+173.12%
2020-12-31	CN¥466.95 Million ≈ $68.33 Million	+12.79%
2019-12-31	CN¥414.01 Million ≈ $60.58 Million	-45.49%
2018-12-31	CN¥759.53 Million ≈ $111.14 Million	+7.34%
2017-12-31	CN¥707.58 Million ≈ $103.54 Million	-29.03%
2016-12-31	CN¥997.00 Million ≈ $145.89 Million	--

About Sirio Pharma

SHE:300791 China Packaged Foods

Market Cap

$785.18 Million

CN¥5.37 Billion CNY

Market Cap Rank

#9868 Global

#2531 in China

Share Price

CN¥17.46

Change (1 day)

+1.69%

52-Week Range

CN¥15.63 - CN¥26.20

All Time High

CN¥57.47